Cannabis in Japan

Cannabis in Japan

Japan is one of the promising CBD markets globally. Growth is expected, supported by the amendment of the Cannabis Control Act in 2023, which also includes the legalisation of medical cannabis. Although the details of the amendment are unclear as of the time of writing, it is expected to clear the ambiguities around CBD-related regulation.

Euromonitor International's Cannabis in Japan market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2026 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.